InvestorsHub Logo
icon url

frenchbroad

05/06/21 9:37 PM

#358342 RE: george h #358341

Not before the Brilacidin trial is more complete. But today some new super sick persons receive a first dose of Brilacidin in their blood. And others receive a last dose. We will know results soon. If Brilacidin can help 10% it will be great value. If Brilacidin can help 30% oui some gouvernments will begin to call. Look at the EU strategy for therapeutics. They want to start to pay for good solutions before the end of 2021.
icon url

sunspotter

05/07/21 3:08 AM

#358352 RE: george h #358341

"What would happen if India or Brazil or any country reviewed the current literature and trial stats and decided to approve Brialcidin for emergency use and ordered a million doses?"

I hope whoever was responsible for such a disgraceful decision would be fired on the spot.

No one knows if brilacidin even works in humans with COVID-19, what the side effects would be for folk already laboring with systemic problems, what the correct dose should be etc. etc.

On the other hand you can be sure that such an administration wouldn't care about IPIX's IP and would manufacture and package the drug by themselves.

So, lose-lose basically.

Fortunately this would never happen.
icon url

shazamm

05/07/21 8:36 AM

#358368 RE: george h #358341

George H., company should dial up Telecheck & verify funds before delivery, I’d imagine a NSF check might be difficult to collect on for the foreseeable future. India government could pay in gold of course, doubt we can pay any bills or a dividend to s/h’s with Brazilian nuts. Have a good w/e as we all stay patient.